INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Key Considerations For Labeling Your Cell Or Gene Therapy

  As sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.

• What Clinical Teams Should Know About Changing Trial Logistics

  The clinical journey is every bit as important as the destination.This paper discusses changing supply logistics and solutions to ensure secure, efficient, cost-effective passage of clinical supplies.

• Clinical Supply Optimization: Enhanced Service Model Saves Client Time On Supplies

  The Vice President of manufacturing for a clinical-stage biopharmaceutical company faced an avalanche of work when a reorganization left him without a clinical supply manager. Planning to start 5 new clinical trials in 6 months while managing quality assurance, manufacturing, and supplies for new and ongoing studies, he turned to his Fisher Clinical Services account executive with a simple question: “How am I going to do all that?”

• What Lies Ahead In 2019? Continued Change For The Cold Chain

  This article offers four predictions from a pharmaceutical packaging solutions company anticipating what will continue to drive change in 2019.

• Reducing Cost Within Advanced Therapy Clinical Trials

  The challenge for advanced therapy companies is that they need to develop a supply chain that delivers their therapy, at scale, without adding significantly to the cost of goods sold (COGS). In this case study, you'll learn how a company saw 55% cost savings across its distribution system and increased visibility of its supply chain through utilizing a Total Transportation Management (TTM) system.

• Off-Site Storage Of Biological Specimens And Biologics For Risk Mitigation

  Choosing an offsite storage facility means asking the right questions to determine if the storage provider has the appropriate risk mitigation infrastructure in place, beginning with a realistic threat assessment.

• Thinking Outside Of The Freezer: DNA And RNA Storage

  While ultra-low temperatures are the current state-of-the-art solution for biospecimen storage, ambient storage is an interesting option and could be superior in certain limited situations. For many types of samples, it’s possible that we will always have to use ultra-low temperatures for long-term storage. For other sample types, such as DNA and RNA, there are alternative solutions.  

• Liquid Retention Comparison In PC And PETG Containers

  Fluid retention is an important consideration when choosing a container. The physical design and material of construction of the container impact how much fluid remains after dispensing. Fluid retention is an important consideration when choosing which container to use. This application note is a comparison between different container products.

• "Validation" Or "Qualification" – What’s The Difference?

  What is the difference between qualification and validation? This question comes up frequently with both internal and external clients.